ANIXA BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
ANIXA BIOSCIENCES, INC. (ANIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.40% for the 12-month period ending 2025-10-31, per its 10-K filed 2026-01-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2026-01-12
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-07-31 was 2.01%, a 4.15% increase year-over-year.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-04-30 was 1.85%, a 0.00% change year-over-year.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2015-01-31 was 1.60%, a 9.09% decline year-over-year.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2014-07-31 was 1.93%.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2025 was 4.40%, a 12.82% increase from fiscal 2024.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.90%, a 0.78% increase from fiscal 2023.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.87%, a 94.47% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.99%, a 188.41% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2025-10-31 | 4.40% 10-K · filed 2026-01-12 | ||||
| 2024-10-31 | 3.90% 10-K · filed 2026-01-12 | 3.87% 10-K · filed 2025-01-10 | |||
| 2023-10-31 | 3.87% 10-K · filed 2025-01-10 | ||||
| 2022-10-31 | 1.99% 10-K · filed 2024-01-16 | ||||
| 2021-10-31 | 0.69% 10-K · filed 2023-01-04 | ||||
| 2020-10-31 | 1.45% 10-K · filed 2022-01-04 | ||||
| 2019-10-31 | 1.61% 10-K · filed 2021-01-07 | ||||
| 2018-10-31 | 2.80% 10-K · filed 2020-01-09 | ||||
| 2017-10-31 | 1.94% 10-K · filed 2019-01-11 | ||||
| 2016-10-31 | 1.26% 10-K · filed 2018-01-09 | ||||
| 2015-10-31 | 2.01% 10-K · filed 2016-12-08 | ||||
| 2015-07-31 | 2.01% 10-Q · filed 2015-08-18 | 1.66% 10-Q · filed 2015-08-18 | |||
| 2015-04-30 | 1.85% 10-Q · filed 2015-05-22 | 1.60% 10-Q · filed 2015-05-22 | |||
| 2015-01-31 | 1.60% 10-Q · filed 2015-03-09 | ||||
| 2014-10-31 | 1.82% 10-K · filed 2015-12-23 | ||||
| 2014-07-31 | 1.93% 10-Q · filed 2015-08-18 | 1.82% 10-Q · filed 2015-08-18 | |||
| 2014-04-30 | 1.85% 10-Q · filed 2014-06-16 | 1.77% 10-Q · filed 2015-05-22 | |||
| 2014-01-31 | 1.76% 10-Q · filed 2015-03-09 | ||||
| 2013-10-31 | 0.73% 10-K · filed 2015-01-29 | ||||
| 2013-07-31 | 0.73% 10-Q · filed 2014-09-15 | ||||
| 2013-04-30 | 0.82% 10-Q · filed 2014-06-16 | 0.73% 10-Q · filed 2014-06-16 | |||
| 2013-01-31 | 0.58% 10-Q · filed 2014-03-17 | ||||
| 2012-10-31 | 1.16% 10-K/A · filed 2014-01-17 | ||||
| 2012-07-31 | 0.20% 10-Q/A · filed 2013-09-20 | ||||
| 2012-04-30 | 0.18% 10-Q/A · filed 2013-06-19 | 0.20% 10-Q/A · filed 2013-06-19 | |||
| 2012-01-31 | 0.20% 10-Q/A · filed 2013-03-25 | ||||
| 2011-07-31 | 1.48% 10-Q · filed 2012-09-14 | 1.05% 10-Q · filed 2012-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |